4-1004329-C-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000203.5(IDUA):c.1898C>G(p.Ser633Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,459,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.1898C>G | p.Ser633Trp | missense_variant | Exon 14 of 14 | 2 | NM_000203.5 | ENSP00000425081.2 | ||
IDUA | ENST00000247933.9 | c.1898C>G | p.Ser633Trp | missense_variant | Exon 14 of 14 | 1 | ENSP00000247933.4 | |||
IDUA | ENST00000514698.5 | n.2009C>G | non_coding_transcript_exon_variant | Exon 11 of 11 | 5 | |||||
IDUA | ENST00000652070.1 | n.1954C>G | non_coding_transcript_exon_variant | Exon 13 of 13 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249054Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135252
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459632Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726210
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11735025, 24480078, 24798265, 32235807, 33389473) -
Mucopolysaccharidosis type 1 Pathogenic:2
This sequence change replaces serine, which is neutral and polar, with tryptophan, which is neutral and slightly polar, at codon 633 of the IDUA protein (p.Ser633Trp). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with mucopolysaccharidosis type I (PMID: 24798265, 33389473). ClinVar contains an entry for this variant (Variation ID: 286242). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on IDUA protein function. This variant disrupts the p.Ser633 amino acid residue in IDUA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11735025, 16438163, 21480867, 26825088, 27146977). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
The p.Ser633Trp variant in IDUA has been reported in at least 4 individuals with mucopolysaccharidosis (MPS) (PMID: 24798265; doi: 10.1016/j.ymgme.2015.12.397) and has been identified in 0.003% (1/34546) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs886043347). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar as pathogenic by EGL Genetic Diagnostics (Variation ID: 286242). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. One additional pathogenic variant, resulting in a different amino acid change at the same position, p.Ser633Leu, has been reported pathogenic in association with disease in the literature and ClinVar, supporting that a change at this position may not be tolerated (PMID: 16438163, 28752568, 11735025, 2448007; VariationID: 556406). The p.Ser633Trp variant is located in a region of IDUA that is important for protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 24480078). The phenotype of individuals homozygous and compound heterozygous for this variant is highly specific for MPS based on a-L-Iduronidase activity being <1% of normal, consistent with disease (PMID: 24798265; doi: 10.1016/j.ymgme.2015.12.397). The presence of this variant in at least 3 affected homozygotes and in combination with a reported pathogenic variant in an individual with MPS increases the likelihood that the p.Ser633Trp variant is pathogenic (VariationID: 11908; PMID: 24798265; doi: 10.1016/j.ymgme.2015.12.397). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PM5, PM3, PP3, PM1_supporting, PP4 (Richards 2015). -
Inborn genetic diseases Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at